Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
3,494
Views
14
CrossRef citations to date
0
Altmetric
Coronaviruses

Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant

Xiaoling Yua Gobond Testing Technology (Beijing) Co., Ltd., Beijing, People’s Republic of ChinaView further author information
,
Xiangrong Qia Gobond Testing Technology (Beijing) Co., Ltd., Beijing, People’s Republic of ChinaView further author information
,
Yu Caob Department of Science and Development, Beijing Youan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaView further author information
,
Peiyao Lia Gobond Testing Technology (Beijing) Co., Ltd., Beijing, People’s Republic of ChinaView further author information
,
Li Luc Yearth Biotechnology Co. Ltd., Changsha, People’s Republic of ChinaView further author information
,
Pingping Wanga Gobond Testing Technology (Beijing) Co., Ltd., Beijing, People’s Republic of ChinaView further author information
,
Yuchen Fenga Gobond Testing Technology (Beijing) Co., Ltd., Beijing, People’s Republic of ChinaView further author information
,
Jie Yanga Gobond Testing Technology (Beijing) Co., Ltd., Beijing, People’s Republic of ChinaView further author information
,
Huihui Weia Gobond Testing Technology (Beijing) Co., Ltd., Beijing, People’s Republic of ChinaView further author information
,
Lixian Guoa Gobond Testing Technology (Beijing) Co., Ltd., Beijing, People’s Republic of ChinaView further author information
,
Mingyue Suna Gobond Testing Technology (Beijing) Co., Ltd., Beijing, People’s Republic of ChinaView further author information
,
Qiang Liua Gobond Testing Technology (Beijing) Co., Ltd., Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Jing Lva Gobond Testing Technology (Beijing) Co., Ltd., Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Yingmei Fengb Department of Science and Development, Beijing Youan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
 show all
Pages 749-752 | Received 29 Dec 2021, Accepted 15 Feb 2022, Published online: 03 Mar 2022

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.